Dr. Daniel Jeremy Waintraub, MD

Dr. Waintraub practices at Gastro Health in Boca Raton, Florida.

Dr. Waintraub's NPI, 1750624037, was assigned on April 4, 2013. Dr. Waintraub graduated from New York Medical College in 2013. Dr. Waintraub holds Florida license ME142523.

Dr. Waintraub's primary practice is Gastro Health, at 7200 Camino Real, Boca Raton, FL 33433 in Palm Beach County. The practice phone is (954) 433-5900.

Dr. Waintraub's primary practice is Gastro Health in Boca Raton, Florida. Dr. Waintraub is also affiliated with Boca Raton Regional Hospital. The medical group on file is Gastro Health. Dmand AI also links Dr. Waintraub to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waintraub practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Waintraub's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Waintraub is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Waintraub's licenses on file in 2 states: Florida and New York.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Waintraub treats.

CMS data shows 1,301 Medicare services from Dr. Waintraub across 15 procedure codes in 2024, for 570 Medicare patients. Medicare paid $126,501 for them.

CMS counts 570 Medicare patients who saw Dr. Waintraub in 2024. The largest group is 65 to 74, with 220 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Waintraub's median patient age at 62, with 56% women.

In 2024, Dr. Waintraub wrote 1,324 Medicare Part D claims for 449 patients. 81% of them were for generic drugs. CMS names the drug for 1,142 of them, across 18 drugs with 11 or more claims each, at $452,891 in total drug cost. In 2023, CMS named 935 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Waintraub for performance year 2024, reported as part of a group. Dr. Waintraub accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Waintraub as offering telehealth. CMS counts 98 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Waintraub, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Waintraub, published from 2015 to 2016. 2015 was the busiest year, with 2. The most frequent topics are Microscopy. Dr. Waintraub has published most often in ACG Case Rep J. Dr. Waintraub's most frequent co-authors are Lionel S. D'Souza, MD, David M. Felig, MD and Gil Ignacio Ascunce, MD.

CMS Open Payments shows 642 general payments to Dr. Waintraub from 39 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $2,633.

Dr. Waintraub graduated from New York Medical College in 2013.

Dr. Waintraub is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.